Advertisement

Journal of Endocrinological Investigation

, Volume 26, Issue 12, pp 1163–1170 | Cite as

“Non-thyroidal illness syndrome” is functional central hypothyroidism, and if severe, hormone replacement is appropriate in light of present knowledge

  • L. J. DeGroot
Opinion

Key-words

Non-thyroidal illness syndrome euthyroid sick syndrome thyroid and illness hypothyroidism low T3 states hypothalamic hypothyroidism thyroid hormone treatment 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    McIver B, Gorman CA. Euthyroid sick syndrome: an overview. Thyroid 1997, 7: 125–32.PubMedCrossRefGoogle Scholar
  2. 2.
    Docter R, Krenning EP, de Jong M, Hennemann G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol 1993, 39: 499–518.CrossRefGoogle Scholar
  3. 3.
    DeGroot LJ. Dangerous dogmas in medicine: The non-thyroidal illness syndrome. J Clin Endocrinol Metab 1999, 84: 151–64.CrossRefGoogle Scholar
  4. 4.
    Van den Berghe G, De Zegher F, Baxter RC, et al. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin Endocrinol Metab 1998, 83: 309–19.PubMedGoogle Scholar
  5. 5.
    Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and lower serum thyroxine concentration. J Clin Endocrinol Metab 1986, 63: 1–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Kaptein EM, MacIntyre SS, Weiner JM, Spencer CA, Nicoloff JT. Free thyroxine estimates in nonthyroidal illness: comparison of eight methods. J Clin Endocrino Metab 1981, 52: 1073–7.CrossRefGoogle Scholar
  7. 7.
    Jirasakuldech B, Schussler GC, Yap MG, Drew H, Josephson A, Michl J. A characteristic serpin cleavage product of thyroxine-binding globulin appears in sepsis sera. J Clin Endocrinol Metab 2000, 85: 3996–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Nagaya T, Fujieda M, Otsuka G, Yang JP, Okamoto T, Seo H. A potential role of activated NF-kappa B in the pathogenesis of euthyroid sick syndrome. J Clin Invest 2000, 106: 393–402.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Yu J, Koenig RJ. Regulation of hepatocyte thyroxine 5′ deiodinase by T3 and nuclear receptor coactivators as a model of the sick euthyroid syndrome. J Biol Chem 2000, 275: 38296–301.PubMedCrossRefGoogle Scholar
  10. 10.
    Berger MM, Reymond MJ, Shenkin A, et al. Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial. Intensive Care Med 2001, 27: 91–100.PubMedCrossRefGoogle Scholar
  11. 11.
    Legradi G, Emerson CH, Ahima RS, Flier JS, Lechan RM. Leptin prevents fasting-induced suppression of prothy-rotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 1997, 138: 2569–76.PubMedGoogle Scholar
  12. 12.
    Legradi G, Emerson CH, Ahima RS, Rand WM, Flier JS, Lechan RM. Arcuate nucleus ablation prevents fastng-induced suppression of proTRH mRNA in the hypotha-amic paraventricular nucleus. Neuroendocrinology 1998, 68: 89–97.PubMedCrossRefGoogle Scholar
  13. 13.
    Spratt DI, Bigos ST, Beitins I, Cox P, Longcope C, Orav J. Both hyper- and hypogonadotropic hypogonadism occur transiently in acute illness: bio- and immunoac-tive gonadotropins. J Clin Endocrinol Metab 1992, 75: 1562–70.PubMedGoogle Scholar
  14. 14.
    Van den Berghe G, de Zegher F, Lauwers P. Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf) 1994, 41: 731–7.CrossRefGoogle Scholar
  15. 15.
    Van den Berghe G, de Zegher F, Bouillon R. Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998, 83: 1827–34.PubMedGoogle Scholar
  16. 16.
    Becker RA, Vaughan GM, Ziegler MG, et al. Hyper-metabolic low triiodothyronine syndrome of burn injury. Crit Care Med 1982, 10: 870–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Acker CG, Singh AR, Flick RP, Bernardini J, Greenberg A, Johnson JP. A trial of thyroxine in acute renal failure. Kidney International 2000, 57: 293–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Siegel NJ, Gaudio KM, Katz LA, et al. Beneficial effect of thyroxine on recovery from toxic acute renal failure. Kidney International 1984, 25: 906–11.PubMedCrossRefGoogle Scholar
  19. 19.
    Acker CG, Flick R, Shapiro R, et al. Thyroid hormone in the treatment of post-transplant acute tubular necrosis. Am J Transplant 2002, 2: 57–61.PubMedCrossRefGoogle Scholar
  20. 20.
    Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 1995, 333: 1522–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Bettendorf M, Schmidt KG. Grulich-Henn J. Ulmer HE. Heinrich UE. Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 2000, 356: 529–34.PubMedCrossRefGoogle Scholar
  22. 22.
    Facktor MA, Mayor GH, Nachreiner RF, D’Alecy LG. Thyroid hormone loss and replacement during resuscitation from cardiac arrest in dogs. Resuscitation 1993, 26: 141–62.PubMedCrossRefGoogle Scholar
  23. 23.
    Hsu R-B, Huang T-S, Chen Y-S, Chu S-H. Effect of triiodothyronine administration in experimental myocardia injury. J Endocrinol Invest 1995, 18: 702–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Shigematsu H, Shatney CH. The effect of triiodothyronine and reverse triiodothyronine on canine hemorrhagic shock. Nippon Geka Gakkai Zasshi 1988, 89: 1587–93.PubMedGoogle Scholar
  25. 25.
    Facktor MA, Mayor GH, Nachreiner RF, D’Alecy LG. Thyroid hormone loss and replacement during resuscitation from cardiac arrest in dogs. Resuscitation 1993, 26: 141–62.PubMedCrossRefGoogle Scholar
  26. 26.
    Katzeff HL, Powell SR, Ojamaa K. Alterations in cardiac contractility and gene expression during low T3 syndrome: prevention with T3. Amer J Physiol 1997, 273: E951–6.PubMedGoogle Scholar
  27. 27.
    Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999, 341: 785–92.PubMedCrossRefGoogle Scholar
  28. 28.
    Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345: 1359–67.PubMedCrossRefGoogle Scholar
  29. 29.
    Herndon DN, Hart DW, Wolf SE, Chinkes DL. Wolfe RR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 2001, 345: 1223–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Merry WH, Caplan RH, Wickus GG, et al. Acute adrena failure due to transient corticotropin deficiency in postoperative patients. Surgery 1994, 116: 1095–100.PubMedGoogle Scholar
  31. 31.
    Kong A, Edmonds P. Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis. Lancet Infect Dis. 2002, 2: 692–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Spinler SA, Hilleman DE, Cheng JW, et al. New recom mendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann Pharmacother 2001, 35: 589–617.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2003

Authors and Affiliations

  1. 1.Thyroid Study UnitThe University of Chicago Medical CenterChicagoUSA

Personalised recommendations